Compare PGC & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PGC | QTRX |
|---|---|---|
| Founded | 1921 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 836.7M | 160.0M |
| IPO Year | 1997 | 2017 |
| Metric | PGC | QTRX |
|---|---|---|
| Price | $45.24 | $2.64 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $40.50 | $6.00 |
| AVG Volume (30 Days) | 140.2K | ★ 802.6K |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.48% | N/A |
| EPS Growth | ★ 13.51 | N/A |
| EPS | ★ 1.65 | N/A |
| Revenue | ★ $282,995,000.00 | $37,632,000.00 |
| Revenue This Year | $32.39 | $25.49 |
| Revenue Next Year | $12.64 | $10.04 |
| P/E Ratio | $27.37 | ★ N/A |
| Revenue Growth | 24.05 | ★ 64.52 |
| 52 Week Low | $24.71 | $2.15 |
| 52 Week High | $49.14 | $8.77 |
| Indicator | PGC | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 41.61 | 39.93 |
| Support Level | $44.85 | $2.27 |
| Resistance Level | $47.47 | $3.74 |
| Average True Range (ATR) | 0.95 | 0.25 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 19.65 | 30.34 |
Peapack Gladstone Financial Corp is a bank holding company. Through its subsidiaries, the company offers various wealth management, investment banking, and commercial and personal banking solutions to its clients. The company has two reportable segments: Banking, which generates the maximum revenue, and Wealth Management. The Banking segment includes commercial, commercial real estate, multifamily, residential, and consumer lending activities; treasury management services; escrow management; deposit generation; operation of ATMs; telephone and internet banking services; credit card services, etc. The Wealth Management segment offers investment management services for individuals and institutions; personal trust services; and other financial planning and advisory services.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.